Literature DB >> 3033889

Altered structure and expression of c-myc in feline T-cell tumours.

D Forrest, D Onions, G Lees, J C Neil.   

Abstract

The c-myc gene is rearranged in a subset of feline T-cell lymphosarcomas. Detailed mapping of c-myc rearrangements showed that some result from feline leukaemia virus (FeLV) proviral integration within or upstream of c-myc, but one case involves a complex 3' alteration and amplification which is apparently not directly virus-induced. S1 nuclease mapping of RNA from normal cells using c-myc probes revealed two presumptive 5' ends, each corresponding to a promoter-like sequence (P1 and P2), and a major 3' discontinuity which mapped to the 3'-most of two possible polyadenylation signals. Analysis of RNA from a series of tumours revealed different modes of c-myc expression. All tumours produced P1 and P2 transcripts with apparently normal structure except for one case where an insertion in intron 1 displaced exon 1 sequences. The abundance ratio of P1/P2 transcripts varied considerably and was high in tumours which carry a rearrangement adjacent to c-myc, but some other T-cell tumours with no apparent myc alteration displayed an equally high ratio. However, a consistent feature was the lack of detectable RNA from normal c-myc alleles in tumours which express a rearranged c-myc allele or a transduced FeLV v-myc gene. We suggest that this may prove to be a useful indicator of the presence of an oncogenically active myc gene, whether this is a rearranged c-myc or transduced v-myc sequence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033889     DOI: 10.1016/0042-6822(87)90253-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT.

Authors:  D L Doggett; A L Drake; V Hirsch; M E Rowe; V Stallard; J I Mullins
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus.

Authors:  D V Kumar; B T Berry; P Roy-Burman
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus.

Authors:  R Fulton; M Plumb; L Shield; J C Neil
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type.

Authors:  K S Levesque; L Bonham; L S Levy
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.

Authors:  M L Jackson; S L Wood; V Misra; D M Haines
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

6.  Negative autoregulation of c-myc transcription.

Authors:  L J Penn; M W Brooks; E M Laufer; H Land
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

7.  Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.

Authors:  C Tsatsanis; R Fulton; K Nishigaki; H Tsujimoto; L Levy; A Terry; D Spandidos; D Onions; J C Neil
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas.

Authors:  R L Sheets; R Pandey; W C Jen; P Roy-Burman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.

Authors:  A Terry; R Fulton; M Stewart; D E Onions; J C Neil
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes.

Authors:  D Forrest; M Sjöberg; B Vennström
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.